Oxygen Biotherapeutics, Inc. to Present at BIO CEO & Investor Conference in New York City on Feb. 10

COSTA MESA, Calif.--(BUSINESS WIRE)--Oxygen Biotherapeutics, Inc. (OTCBB:OXBO) today announced that company chairman and CEO Chris J. Stern, DBA will present at the 11^th Annual BIO CEO & Investor Conference in New York on February 10 at 2:45 p.m. eastern time.

A live webcast of the presentation will be available through the Investor Relations section of the Oxygen Biotherapeutics, Inc. website at www.oxybiomed.com. A replay will be available following the event. Webcast login information will be provided on the website prior to the presentation.

About Oxygen Biotherapeutics, Inc.

Oxygen Biotherapeutics, Inc. is dedicated to commercializing innovative pharmaceuticals and medical devices in the field of oxygen therapeutics and continuous substrate monitoring. The company has under development a perfluorocarbon (PFC) therapeutic oxygen carrier and liquid ventilation product (Oxycyte®) and an implantable glucose sensor. These products are based upon core technologies that include biomedical applications for PFCs and medical and industrial applications for biosensors. Each of the product candidates is designed with advantages over currently marketed products in major markets including traumatic brain injury, sickle cell crisis pain, trauma, wound care, acute respiratory distress syndrome, stroke, myocardial infarction, surgery, and diabetes. More information is available on the company website at www.oxybiomed.com.